BAM Group LLC d/b/a VapEscape

Warning LetterOpen

United StatesIssued May 11, 2023Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateMay 11, 2023

Product TypeTobacco

StatusOpen

Letter Details

Firm: BAM Group LLC d/b/a VapEscape
Location: United States
FEI Number: N/A
Country: United States
Issue Date: May 11, 2023
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Based on limited metadata, BAM Group LLC d/b/a VapEscape received an FDA Warning Letter on May 11, 2023, regarding tobacco products, likely vapor or electronic nicotine delivery products based on the company name. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's tobacco regulatory authority, though the specific issuing office is not identified in this metadata. Additional details would be needed to characterize the specific compliance issues cited.

BAM Group LLC d/b/a VapEscape FDA Warning Letter, May 11, 2023